FIBROBODY Trademark

Trademark Overview


On Thursday, February 18, 2021, a trademark application was filed for FIBROBODY with the United States Patent and Trademark Office. The USPTO has given the FIBROBODY trademark a serial number of 79321550. The federal status of this trademark filing is REGISTERED as of Tuesday, January 25, 2022. This trademark is owned by LinXis B.V.. The FIBROBODY trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations for the treatment of fibrotic disease, liver- kidney- and lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; drug delivery agents in the form of parenteral formulations and per-oral formulations, tablets and capsules that facilitate the delivery of pharmaceutical preparations; pharmaceutical drugs for the treatment of fibrotic disease, liver- kidney- and lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; drug delivery agents in the form of parenteral formulations and per-oral formulations, tablets and capsules that facilitate the delivery of pharmaceutical preparations; biochemical medicines for the treatment of fibrotic disease, liver- kidney- and lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; chemical preparations for pharmaceutical purposes, namely, for the treatment of f...

Chemical additives for use in the manufacture of pharmaceuticals; chemical preparations for use in the manufacture of pharmaceuticals; active chemical ingredients for use in the manufacture of pharmaceuticals for treating fibrotic disease, liver- kidney- and lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease

Medical services, namely, in vitro analysis for medical and pharmaceutical use; medical services, namely, in vitro testing for medical and pharmaceutical use; consultancy and information services provided via the internet relating to pharmaceutical products

Pharmaceutical research services; conducting clinical trials for others relating to pharmaceuticals; pharmaceutical research and development; pharmaceutical product evaluation; consultancy relating to pharmaceutical research and development; laboratory research services relating to pharmaceuticals; providing information about the results of clinical trials for pharmaceuticals; providing information about medical and scientific research in the field of pharmaceuticals; scientific research services in the field of proteins, antibodies, microorganisms and cells; research and development services in the field of antibody technology; design and development of medical technology
fibrobody

General Information


Serial Number79321550
Word MarkFIBROBODY
Filing DateThursday, February 18, 2021
Status700 - REGISTERED
Status DateTuesday, January 25, 2022
Registration Number6624524
Registration DateTuesday, January 25, 2022
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 9, 2021

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of fibrotic disease, liver- kidney- and lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; drug delivery agents in the form of parenteral formulations and per-oral formulations, tablets and capsules that facilitate the delivery of pharmaceutical preparations; pharmaceutical drugs for the treatment of fibrotic disease, liver- kidney- and lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; drug delivery agents in the form of parenteral formulations and per-oral formulations, tablets and capsules that facilitate the delivery of pharmaceutical preparations; biochemical medicines for the treatment of fibrotic disease, liver- kidney- and lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; chemical preparations for pharmaceutical purposes, namely, for the treatment of fibrotic disease, liver- kidney- and lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; diagnostic agents for pharmaceutical purposes; pharmaceutical substances and preparations for the treatment of fibrotic disease, liver- kidney- and lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; drug delivery agents consisting of compounds that facilitate delivery of pharmaceutical preparations
Pseudo MarkFIBRO BODY
Goods and ServicesChemical additives for use in the manufacture of pharmaceuticals; chemical preparations for use in the manufacture of pharmaceuticals; active chemical ingredients for use in the manufacture of pharmaceuticals for treating fibrotic disease, liver- kidney- and lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease
Goods and ServicesMedical services, namely, in vitro analysis for medical and pharmaceutical use; medical services, namely, in vitro testing for medical and pharmaceutical use; consultancy and information services provided via the internet relating to pharmaceutical products
Goods and ServicesPharmaceutical research services; conducting clinical trials for others relating to pharmaceuticals; pharmaceutical research and development; pharmaceutical product evaluation; consultancy relating to pharmaceutical research and development; laboratory research services relating to pharmaceuticals; providing information about the results of clinical trials for pharmaceuticals; providing information about medical and scientific research in the field of pharmaceuticals; scientific research services in the field of proteins, antibodies, microorganisms and cells; research and development services in the field of antibody technology; design and development of medical technology

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateWednesday, October 6, 2021
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 6, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, October 6, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, October 6, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLinXis B.V.
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressNL

Party NameLinXis B.V.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNL

Party NameLinXis B.V.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNL

Trademark Events


Event DateEvent Description
Wednesday, October 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 6, 2021ASSIGNED TO EXAMINER
Wednesday, October 6, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 12, 2021APPLICATION FILING RECEIPT MAILED
Thursday, September 30, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, October 4, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Tuesday, January 25, 2022REGISTERED-PRINCIPAL REGISTER
Wednesday, May 18, 2022FINAL DISPOSITION PROCESSED
Friday, September 20, 2024CHANGE OF NAME/ADDRESS REC'D FROM IB
Wednesday, October 20, 2021NOTICE OF PUBLICATION
Tuesday, November 9, 2021PUBLISHED FOR OPPOSITION
Thursday, February 24, 2022GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Thursday, May 19, 2022FINAL DISPOSITION NOTICE SENT TO IB
Sunday, June 5, 2022NOTIFICATION PROCESSED BY IB
Friday, September 19, 2025NEW REPRESENTATIVE AT IB RECEIVED
Friday, March 14, 2025CHANGE OF NAME/ADDRESS REC'D FROM IB